Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.53
-0.0200-0.04%
Post-market: 49.530.00000.00%16:41 EDT
Volume:593.75K
Turnover:29.44M
Market Cap:3.91B
PE:-10.48
High:50.07
Open:49.11
Low:48.09
Close:49.55
Loading ...

PTC Therapeutics: Phase 2 CardinALS study did not meet its primary endpoint

TIPRANKS
·
27 Nov 2024

PTC Therapeutics Inc - Study Failed to Meet Primary and Secondary Efficacy Endpoints

THOMSON REUTERS
·
27 Nov 2024

PTC Therapeutics Inc - Utreloxastat Was Demonstrated to Be Safe and Well Tolerated in Cardinals Trial

THOMSON REUTERS
·
27 Nov 2024

PTC Therapeutics Inc - Further Development of Utreloxastat Not Planned

THOMSON REUTERS
·
27 Nov 2024

PTC Therapeutics Announces Topline Results of Cardinals Trial of Utreloxastat in ALS Patients

THOMSON REUTERS
·
27 Nov 2024

PTC Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
26 Nov 2024

Wells Fargo Remains a Buy on PTC Therapeutics (PTCT)

TIPRANKS
·
26 Nov 2024

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
26 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
23 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
20 Nov 2024

J.P. Morgan Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
19 Nov 2024

U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix

Reuters
·
19 Nov 2024

Biotech-stock investing has one tough test for success - and it's about to get easier

Dow Jones
·
18 Nov 2024

FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain

Benzinga
·
15 Nov 2024

Sector Update: Health Care Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
14 Nov 2024

BRIEF-FDA Approves First Gene Therapy For Treatment Of Aromatic L-Amino Acid Decarboxylase Deficiency

Reuters
·
14 Nov 2024

FDA Approves First Gene Therapy for Treatment of Aromatic L-Amino Acid Decarboxylase Deficiency

THOMSON REUTERS
·
14 Nov 2024

FDA- FDA Granted Approval of Kebilidi to PTC Therapeutics, Inc

THOMSON REUTERS
·
14 Nov 2024

Top Premarket Gainers

MT Newswires Live
·
14 Nov 2024

PTC Therapeutics Shares up 10.8% Premarket After FDA Approves Co's Gene Therapy

THOMSON REUTERS
·
14 Nov 2024